# Placebo-Controlled Study of Terpenes-Enriched Cannabis Oil T1/C28 for Children With Autism

> **NCT07199218** · PHASE2 · RECRUITING · sponsor: **Bazelet Nehushtan LtD.** · enrollment: 78 (estimated)

## Conditions studied

- Autism
- Autism Spectrum Disorder

## Interventions

- **DRUG:** Terpenes-Enriched CBD-Predominant Oil
- **DRUG:** Placebo
- **DRUG:** Terpenes-Enriched CBD Oil (THC-Free)

## Key facts

- **NCT ID:** NCT07199218
- **Lead sponsor:** Bazelet Nehushtan LtD.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-05
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-03-03
- **Target enrollment:** 78 (ESTIMATED)
- **Last updated:** 2025-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07199218

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07199218, "Placebo-Controlled Study of Terpenes-Enriched Cannabis Oil T1/C28 for Children With Autism". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07199218. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*